Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Poly Pharm is a specialized pharmaceutical company based in China that focuses on the research, development, manufacturing, and international marketing of high-quality generic drugs and contrast agents. The company has established a significant global footprint, with numerous products receiving approvals from the US FDA, EU authorities, and the WHO. Their product portfolio spans several therapeutic areas, including anti-infectives, antihistamines, and cardiovascular treatments, with a particular emphasis on complex injectable formulations. Hainan Poly Pharm operates advanced manufacturing facilities that comply with international GMP standards, enabling them to serve as a reliable supplier in both domestic and highly regulated overseas markets. The company continues to expand its pipeline into high-barrier generics and innovative drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Poly.